
Licensing
ENABLING NEXT GENERATION CURES
The new possibilities with advanced, novel therapeutics have transformed the way pharmaceutical and biotech companies have approached drug discovery and development. With the surge in immunologic, cell and gene therapies, we are pleased to offer a comprehensive, validated, and broad range of licensing opportunities that can help you develop a robust, innovative pipeline.
We are here to support you whether you decide to in-license technologies, develop an in-house processing capability, scale manufacturing, or de-risk regulatory approvals.
Our long-term commitment, attention to details and result-oriented approach, with years of experience in developing and handling highly complex biological materials such as viral vectors, cell lines, and gene modulation and editing technology can help bring your therapy to market.
For research use only. Not for use in diagnostic procedures.
Explore Our Solutions
Featured Resources
Featured Products

